Alnylam Licenses RNAi Patent to RNAx

genomeweb
360dx

Alnylam Licenses RNAi Patent to RNAx

Jan 27, 2004

NEW YORK, Jan. 27 (GenomeWeb News) - Alnylam Pharmaceuticals, through its German affiliate, Ribopharma, has granted a license to its RNAi patent to Ribopharma, the company said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

DOJ Investigating Genomic Health for Compliance Issues With Medicare Billing Regulations
People in the News: William Denman, Rolland Carlson, Tanja Dowe, Katleen Verleysen, Greg Shaw
Atherosclerotic Plaques Reveal Differentially Expressed MicroRNAs
In Brief This Week: Agilent, Qiagen, Invitae, and More
MedSeq Project Yields Algorithm for Extensive Blood Typing
New Products Posted to GenomeWeb: Oxford Nanopore, Invivoscribe, Precipio, More

The Scan

From Relatives to Suspects

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

Family Ties

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

Time to Kick Back With Some Golf

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

This Week in Science

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

Main menu